Aurisco Pharmaceutical Statistics
Total Valuation
SHA:605116 has a market cap or net worth of CNY 6.78 billion. The enterprise value is 7.15 billion.
Important Dates
The last earnings date was Saturday, October 31, 2026.
| Earnings Date | Oct 31, 2026 |
| Ex-Dividend Date | Jun 15, 2026 |
Share Statistics
SHA:605116 has 403.41 million shares outstanding. The number of shares has increased by 2.75% in one year.
| Current Share Class | 403.41M |
| Shares Outstanding | 403.41M |
| Shares Change (YoY) | +2.75% |
| Shares Change (QoQ) | -0.39% |
| Owned by Insiders (%) | 73.95% |
| Owned by Institutions (%) | 4.12% |
| Float | 91.77M |
Valuation Ratios
The trailing PE ratio is 21.78.
| PE Ratio | 21.78 |
| Forward PE | n/a |
| PS Ratio | 4.08 |
| PB Ratio | 2.50 |
| P/TBV Ratio | 2.65 |
| P/FCF Ratio | 214.24 |
| P/OCF Ratio | 17.15 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 12.46, with an EV/FCF ratio of 225.90.
| EV / Earnings | 22.78 |
| EV / Sales | 4.31 |
| EV / EBITDA | 12.46 |
| EV / EBIT | 16.96 |
| EV / FCF | 225.90 |
Financial Position
The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.36.
| Current Ratio | 3.67 |
| Quick Ratio | 2.07 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.68 |
| Debt / FCF | 30.50 |
| Interest Coverage | 12.13 |
Financial Efficiency
Return on equity (ROE) is 11.99% and return on invested capital (ROIC) is 11.90%.
| Return on Equity (ROE) | 11.99% |
| Return on Assets (ROA) | 6.38% |
| Return on Invested Capital (ROIC) | 11.90% |
| Return on Capital Employed (ROCE) | 11.22% |
| Weighted Average Cost of Capital (WACC) | 3.63% |
| Revenue Per Employee | 826,458 |
| Profits Per Employee | 156,232 |
| Employee Count | 2,026 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.14 |
Taxes
In the past 12 months, SHA:605116 has paid 52.46 million in taxes.
| Income Tax | 52.46M |
| Effective Tax Rate | 14.22% |
Stock Price Statistics
The stock price has decreased by -26.49% in the last 52 weeks. The beta is -0.10, so SHA:605116's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | -26.49% |
| 50-Day Moving Average | 19.00 |
| 200-Day Moving Average | 22.26 |
| Relative Strength Index (RSI) | 35.93 |
| Average Volume (20 Days) | 1,748,823 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:605116 had revenue of CNY 1.67 billion and earned 316.53 million in profits. Earnings per share was 0.77.
| Revenue | 1.67B |
| Gross Profit | 898.20M |
| Operating Income | 425.08M |
| Pretax Income | 368.99M |
| Net Income | 316.53M |
| EBITDA | 571.87M |
| EBIT | 425.08M |
| Earnings Per Share (EPS) | 0.77 |
Full Income Statement Balance Sheet
The company has 601.36 million in cash and 973.38 million in debt, with a net cash position of -372.01 million or -0.92 per share.
| Cash & Cash Equivalents | 601.36M |
| Total Debt | 973.38M |
| Net Cash | -372.01M |
| Net Cash Per Share | -0.92 |
| Equity (Book Value) | 2.74B |
| Book Value Per Share | 6.63 |
| Working Capital | 1.27B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 398.64 million and capital expenditures -366.73 million, giving a free cash flow of 31.92 million.
| Operating Cash Flow | 398.64M |
| Capital Expenditures | -366.73M |
| Depreciation & Amortization | 146.79M |
| Net Borrowing | -43.15M |
| Free Cash Flow | 31.92M |
| FCF Per Share | 0.08 |
Full Cash Flow Statement Margins
Gross margin is 53.64%, with operating and profit margins of 25.39% and 18.90%.
| Gross Margin | 53.64% |
| Operating Margin | 25.39% |
| Pretax Margin | 22.04% |
| Profit Margin | 18.90% |
| EBITDA Margin | 34.15% |
| EBIT Margin | 25.39% |
| FCF Margin | 1.91% |
Dividends & Yields
This stock pays an annual dividend of 0.34, which amounts to a dividend yield of 2.02%.
| Dividend Per Share | 0.34 |
| Dividend Yield | 2.02% |
| Dividend Growth (YoY) | 17.24% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 45.18% |
| FCF Payout Ratio | 429.74% |
| Buyback Yield | -2.75% |
| Shareholder Yield | -0.75% |
| Earnings Yield | 4.59% |
| FCF Yield | 0.47% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:605116 has an Altman Z-Score of 5.29 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.29 |
| Piotroski F-Score | 4 |